Search
for
Sort by
Research 451–480 of 782
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Surgical Management of Scarring Alopecia
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Cemiplimab-Induced Alopecia Areata
- JAK inhibitors in dermatology: The promise of a new drug class
- Granzyme B in Autoimmune Skin Disease
- Low-sulfur hair syndrome associated with UVB photosensitivity and testicular failure
- Female Pattern Hair Loss
- Lichen Planopilaris in the Androgenetic Alopecia Area: A Pitfall for Hair Transplantation
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Hair and Scalp Disorders
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Lichen Planopilaris: The first biopsy layer microbiota inspection
- It is not invisible! A case report of 2 patients with scalp Lichen Planopilaris mimicking Androgenic Alopecia
- Inflammatory Phenomena and Fibrosis in Androgenetic Alopecia
- Androgenetic alopecia
- Frequency of Types of Alopecia in a Single-centre Hair Referral Clinic Over a Ten Years Period
- Bicalutamide: A review
- Scalp trauma in lichen planopilaris: Case reports of disease progression from fire fighter helmet use
- Alopecias: Practical Tips for the Management of Biopsies and Main Diagnostic Clues for General Pathologists and Dermatopathologists
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Androgenetic Alopecia
- Scalp Micropigmentation
- Hair loss in women
- CXCL12 Drives Reversible Fibroimmune Remodeling in Androgenetic Alopecia Revealed by Single-Cell RNA Sequencing
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Actinic keratosis: a clinical and epidemiological revision
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice